Aerial shot of Cambridge Biomedical Campus

Cambridge Biomedical Campus celebrates 60 years with £2bn boost to UK economy

02 September 2022

A newÌýeconomic impact reportÌý details the financial contributions of the Cambridge Biomedical Campus (CBC), which celebrates its 60th anniversary this autumn. ̽»¨Ö±²¥independent report by the Centre for Economics and Business Research (Cebr) for the first time calculates the economic benefits of CBC also highlights the health and research benefits for the region.

Read More
Cambridge Biomedical Campus

̽»¨Ö±²¥ of Cambridge launches roadmap to support future growth of life sciences cluster

16 July 2021

Connect: Health Tech, the ̽»¨Ö±²¥ of Cambridge Enterprise Zone, has today launched a roadmap, ‘Creating a ̽»¨Ö±²¥ Enterprise Zone for Cambridge across the life and physical sciences’, that examines the challenges faced in futureproofing and sustaining the growth of the life sciences cluster to maintain Cambridge as a global centre of excellence for health tech.

Read More

Drugs: how to pick a winner in clinical trials

26 June 2017

When a drug fails late on in clinical trials it’s a major setback for launching new medicines. It can cost millions, even billions, of research and development funds. Now, an ‘adaptive’ approach to clinical trials and a genetic tool for predicting success are increasing the odds of picking a winner.Ìý

Read More
Elderly hands

Cambridge Drug Discovery Institute to fast-track development of new treatments for dementia

16 February 2015

Alzheimer’s Research UK, the world’s largest dedicated dementia research charity, has announced a £30 million Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at the Universities of Cambridge, Oxford and UCL ( ̽»¨Ö±²¥ College London). ̽»¨Ö±²¥Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments for Alzheimer’s disease and other dementias.

Read More

Pages